Hamlet Pharma secures a new Alpha1H production batch for continued clinical trials
Lund, May 31, Hamlet Pharma soon to be Hamlet BioPharma, the innovative pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, announces that Hamlet Pharma has secured the production of larger quantities of Alpha1H. The new batch will be essential to extend the clinical trial program in patients with bladder cancer.
Dela artikeln
Taggar: hamlet, pharma, secures
Läs vidare på Dagens Industri